(PRAM) Amundi Prime Emerging - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU2300295123 • Global Emerging Markets Equity
PRAM: Equities, Stocks, Emerging Markets
Amundi Prime Emerging Markets UCITS ETF DR (C) is an exchange-traded fund listed on XETRA under the ticker symbol PRAM. It is domiciled in Germany and focuses on providing exposure to global emerging markets equities. The fund tracks the Morningstar EM TME NR USD index, offering investors access to a diversified portfolio of emerging market stocks.
From a technical perspective, PRAM has shown a recent price of 17.80, with short-term moving averages indicating potential resistance. The SMA 20 at 18.41 and SMA 50 at 18.19 suggest the fund is currently below its recent averages, while the SMA 200 at 17.69 indicates longer-term support. The ATR of 0.19 reflects relatively low volatility in recent trading activity, with an average daily volume of 5,823 shares over the past 20 days.
Fundamentally, the ETF manages assets under management (AUM) of 28.35 million EUR, positioning it as a modestly sized fund within the emerging markets equity category. This size allows for efficient tracking of the underlying index while maintaining liquidity for investors.
3-month forecast:
Based on
Additional Sources for PRAM ETF
PRAM ETF Overview
Market Cap in USD | 31m |
Category | Global Emerging Markets Equity |
TER | 0.10% |
IPO / Inception | 2021-09-14 |
PRAM ETF Ratings
Growth 5y | 11.6% |
Fundamental | - |
Dividend | 0.0% |
Rel. Strength Industry | -14.1 |
Analysts | - |
Fair Price Momentum | 16.27 EUR |
Fair Price DCF | - |
PRAM Dividends
No Dividends PaidPRAM Growth Ratios
Growth Correlation 3m | 8.4% |
Growth Correlation 12m | 79.6% |
Growth Correlation 5y | 8.9% |
CAGR 5y | -2.37% |
CAGR/Max DD 5y | -0.08 |
Sharpe Ratio 12m | 0.62 |
Alpha | 2.66 |
Beta | 0.55 |
Volatility | 19.03% |
Current Volume | 8.4k |
Average Volume 20d | 4.4k |
As of March 15, 2025, the stock is trading at EUR 17.84 with a total of 8,402 shares traded.
Over the past week, the price has changed by +0.24%, over one month by -3.28%, over three months by -1.77% and over the past year by +9.46%.
Neither. Based on ValueRay Analyses, Amundi Prime Emerging is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 11.60 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PRAM as of March 2025 is 16.27. This means that PRAM is currently overvalued and has a potential downside of -8.8%.
Amundi Prime Emerging has no consensus analysts rating.
According to ValueRays Forecast Model, PRAM Amundi Prime Emerging will be worth about 18.1 in March 2026. The stock is currently trading at 17.84. This means that the stock has a potential upside of +1.23%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 18.1 | 1.2% |